Recent advances in the pharmacology of catecholamines
- 1 December 1977
- journal article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 3 (4) , 233-236
- https://doi.org/10.1007/bf01641112
Abstract
The availability of dopamine and dobutamine and the possibility of combined use of sympathomimetic amines provides a broad spectrum of haemodynamic effects available for therapy. As shown in Table 2, isoproterenol produces the greatest vasodilation and norepinephrine, the greatest vasoconstriction with dobutamine and dopamine in intermediate positions. Greater flexibility can be obtained by conjoint administration of sympathomimetic amines or by administering alpha-adrenergic blocking agents, or nitroprusside with dopamine or norepinephrine.Keywords
This publication has 4 references indexed in Scilit:
- Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction.Circulation, 1977
- Newer catecholamines for treatment of heart failure and shock: An update on dopamine and a first look at dobutamineProgress in Cardiovascular Diseases, 1977
- Dopamine — Clinical Uses of an Endogenous CatecholamineNew England Journal of Medicine, 1974
- The potential role of dopamine in the treatment of shockProgress in Cardiovascular Diseases, 1969